718 related articles for article (PubMed ID: 26025474)
1. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
[TBL] [Abstract][Full Text] [Related]
2. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
[TBL] [Abstract][Full Text] [Related]
3. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S
Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563
[TBL] [Abstract][Full Text] [Related]
4. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR.
Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q
Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity.
Manley S; Ni HM; Williams JA; Kong B; DiTacchio L; Guo G; Ding WX
Redox Biol; 2014; 2():991-1002. PubMed ID: 25460735
[TBL] [Abstract][Full Text] [Related]
6. Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.
Xu MJ; Cai Y; Wang H; Altamirano J; Chang B; Bertola A; Odena G; Lu J; Tanaka N; Matsusue K; Matsubara T; Mukhopadhyay P; Kimura S; Pacher P; Gonzalez FJ; Bataller R; Gao B
Gastroenterology; 2015 Oct; 149(4):1030-41.e6. PubMed ID: 26099526
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
[TBL] [Abstract][Full Text] [Related]
8. Role of Fn14 in acute alcoholic steatohepatitis in mice.
Karaca G; Xie G; Moylan C; Swiderska-Syn M; Guy CD; Krüger L; Machado MV; Choi SS; Michelotti GA; Burkly LC; Diehl AM
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G325-34. PubMed ID: 25524063
[TBL] [Abstract][Full Text] [Related]
9. Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency.
Huang M; Kong B; Zhang M; Rizzolo D; Armstrong LE; Schumacher JD; Chow MD; Lee YH; Joseph LB; Stofan M; Zhang L; Guo GL
Lab Invest; 2020 Sep; 100(9):1158-1168. PubMed ID: 32404932
[TBL] [Abstract][Full Text] [Related]
10. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis.
Liu H; Pathak P; Boehme S; Chiang JL
J Lipid Res; 2016 Oct; 57(10):1831-1844. PubMed ID: 27534992
[TBL] [Abstract][Full Text] [Related]
12. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Chow MD; Lee YH; Guo GL
Mol Aspects Med; 2017 Aug; 56():34-44. PubMed ID: 28442273
[TBL] [Abstract][Full Text] [Related]
13. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
Zhang S; Wang J; Liu Q; Harnish DC
J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
[TBL] [Abstract][Full Text] [Related]
15. MitoNEET Deficiency Alleviates Experimental Alcoholic Steatohepatitis in Mice by Stimulating Endocrine Adiponectin-Fgf15 Axis.
Hu X; Jogasuria A; Wang J; Kim C; Han Y; Shen H; Wu J; You M
J Biol Chem; 2016 Oct; 291(43):22482-22495. PubMed ID: 27573244
[TBL] [Abstract][Full Text] [Related]
16. The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.
Levin I; Petrasek J; Szabo G
Alcohol Clin Exp Res; 2012 Aug; 36(8):1397-406. PubMed ID: 22376231
[TBL] [Abstract][Full Text] [Related]
17. FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease.
Li L; Kong L; Xu S; Wang C; Gu J; Luo H; Meng Q
Hepatol Int; 2024 Feb; 18(1):188-205. PubMed ID: 38183609
[TBL] [Abstract][Full Text] [Related]
18. Mouse Model of Alcoholic Steatohepatitis.
Bertola A
Methods Mol Biol; 2020; 2164():145-157. PubMed ID: 32607891
[TBL] [Abstract][Full Text] [Related]
19. Altered ethanol metabolism and increased oxidative stress enhance alcohol-associated liver injury in farnesoid X receptor-deficient mice.
Morel C; Chowdhary V; Thevkar Nagesh P; Ribeiro M; Hawryluk D; Catalano D; Adorini L; Szabo G
Liver Int; 2023 Jan; 43(1):100-114. PubMed ID: 35869657
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of Both Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Exacerbated Liver Fibrosis in Mice.
Ferrell JM; Pathak P; Boehme S; Gilliland T; Chiang JYL
Hepatology; 2019 Sep; 70(3):955-970. PubMed ID: 30664797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]